A carregar...
The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma
The BCL-2 protein family members inhibit cellular apoptosis, and their overexpression represents a common survival adaption in cancer. Recently, a selective BCL-2 inhibitor ABT-199, venetoclax, has demonstrated remarkable activity in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic...
Na minha lista:
| Publicado no: | Blood Lymphat Cancer |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6859801/ https://ncbi.nlm.nih.gov/pubmed/32009829 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BLCTT.S177009 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|